Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Not for profit to offer 20 generic drugs in 2019 to alleviate shortages

      Not for profit to offer 20 generic drugs in 2019 to alleviate shortages

      Medical Dialogues Bureau27 Jan 2019 9:15 AM IST
      Within three-to-five years, it aims to offer up to 100 generic drugs critical to the everyday function of its member hospitals.New York: A new...
      Polyplastics develops new DURACON(R) POM PM Series for medical, healthcare industry

      Polyplastics develops new DURACON(R) POM PM Series for medical, healthcare industry

      Medical Dialogues Bureau27 Jan 2019 9:00 AM IST
      The first grade under the PM series, DURACON POM PM09S01N, delivers global medical and food regulatory compliance.TOKYO: The Polyplastics Group has...
      Glenmark gets USFDA nod for Topiramate extended release capsules

      Glenmark gets USFDA nod for Topiramate extended release capsules

      Medical Dialogues Bureau26 Jan 2019 9:30 AM IST
      Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration for Topiramate extended-release...
      U.S. insulin costs per patient nearly doubled from 2012 to 2016: study

      U.S. insulin costs per patient nearly doubled from 2012 to 2016: study

      Medical Dialogues Bureau26 Jan 2019 9:00 AM IST
      A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that at $2,864 per...
      Damage Control: Sun Pharma replaces domestic formulations distributor with its own subsidiary

      Damage Control: Sun Pharma replaces domestic formulations distributor with its own subsidiary

      Medical Dialogues Bureau24 Jan 2019 1:59 PM IST
      "This liability was in respect of Atlas assuming the damages on account of Protonix patent litigation settlement entered by Sun Pharma which was...
      Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

      Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

      Medical Dialogues Bureau24 Jan 2019 9:30 AM IST
      Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration for Abiraterone Acetate tablets...
      Bayer asks judge to limit evidence in another round up cancer trial

      Bayer asks judge to limit evidence in another round up cancer trial

      Medical Dialogues Bureau24 Jan 2019 9:15 AM IST
      Bayer denies allegations that glyphosate causes cancer, saying decades of independent studies have shown the world's most widely-used weed killer to...
      China slaps anti dumping duties on chemical from India, Japan

      China slaps anti dumping duties on chemical from India, Japan

      Medical Dialogues Bureau24 Jan 2019 9:00 AM IST
      Significantly, the anti-dumping duties announcement coincided with the trade talks between visiting Commerce Secretary Anup Wadhawan and Chinese Vice...
      Lupin gets USFDA nod to market Levothyroxine Sodium tablets

      Lupin gets USFDA nod to market Levothyroxine Sodium tablets

      Medical Dialogues Bureau23 Jan 2019 9:30 AM IST
      According to IQVIA MAT September 2018 data, Levothyroxine Sodium tablets had an annual sale of about USD 2.5 billion in the US market, Lupin said.New...
      Fall in customs duty likely on certain medical devices

      Fall in customs duty likely on certain medical devices

      Medical Dialogues Bureau22 Jan 2019 2:04 PM IST
      Industry chamber CII in its has pre-budget memorandum has asked the government to reduce customs duty from 10 per cent to 2.5 per cent on PDS Plates...
      Extradition process against 4 Sterling Biotech promoters initiated: ED tells court

      Extradition process against 4 Sterling Biotech promoters initiated: ED tells court

      Medical Dialogues Bureau22 Jan 2019 1:17 PM IST
      The ED told the court that the four accused are reported to be in Italy and Nigeria and their extradition is required for probing the case.NEW DELHI:...
      Sun pharma seeks SEBI intervention after allegations of unfair trade practices

      Sun pharma seeks SEBI intervention after allegations of unfair trade practices

      Medical Dialogues Bureau20 Jan 2019 10:15 AM IST
      Against the backdrop of reports that a second whistleblower complaint has been filed against it and shares taking a beating on the exchanges, Sun...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok